Hypoxic dose, intensity distribution, and fatigue monitoring are paramount for "live high-train low" effectiveness

Franck Brocherie (1) , L. Schmitt (2) , Grégoire P. Millet (3)

1 SEP (EA7370) - French Institute of Sport (INSEP), Laboratory Sport, Expertise and Performance (EA7370)
2 Centre National de Ski Nordique
3 ISSUL - Institute of Sport Sciences of University of Lausanne

This article is a comment on: Endurance, aerobic high-intensity, and repeated sprint cycling performance is unaffected by normobaric “Live High-Train Low”: a double-blind placebo-controlled cross-over study, by Bejder J, Andersen AB, Buchardt R, Larsson TH, Olsen NV, Nordsborg NB. Eur J Appl Physiol (2017) 117:979–988.

Domaines: Sciences de l'Homme et Société; Sport; Sciences de l'Homme et Société; Sport; Physiologie du sport

Franck Brocherie, L. Schmitt, Grégoire P. Millet. Hypoxic dose, intensity distribution, and fatigue monitoring are paramount for "live high-train low" effectiveness. European Journal of Applied Physiology, 2017. ⟨hal-02108661⟩